Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

KALA BIO, Inc. Common Stock

KALA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of KALA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
KALA Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
KALA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
KALA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in KALA holdings by institutional investors

Quarterly net insider trading by KALA's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for KALA

Quiver Logo

No former government officials on record as having lobbied for KALA

Revolving Door Dashboard

KALA Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

KALA Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
KALA Income Statement
KALA Balance Sheet
KALA Cash Flow
U.S. Patents

New KALA patent grants

  • Patent Title: Crystalline forms of therapeutic compounds and uses thereof Aug. 01, 2023
  • Patent Title: Biochemical binding of ret9 and vegfr2 inhibitors Aug. 02, 2022
  • Patent Title: Therapeutic compounds and uses thereof Jun. 28, 2022
  • Patent Title: Urea derivatives and uses thereof Jun. 07, 2022
  • Patent Title: Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus May. 03, 2022
  • Patent Title: Crystalline forms of therapeutic compounds and uses thereof Aug. 31, 2021
  • Patent Title: Meropenem derivatives and uses thereof Aug. 17, 2021
  • Patent Title: Crystalline forms of therapeutic compounds and uses thereof Jun. 01, 2021
  • Patent Title: Crystalline forms of therapeutic compounds and uses thereof Apr. 13, 2021
  • Patent Title: Therapeutic compounds and uses thereof Apr. 06, 2021
  • Patent Title: Compounds and uses thereof Mar. 23, 2021
  • Patent Title: 1-amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof Dec. 29, 2020
  • Patent Title: Crystalline forms of therapeutic compounds and uses thereof Sep. 08, 2020
  • Patent Title: Therapeutic compounds and uses thereof Sep. 01, 2020
  • Patent Title: Urea derivatives and uses thereof Jul. 28, 2020
  • Patent Title: Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus Jun. 23, 2020
  • Patent Title: Compounds and uses thereof Jan. 28, 2020
  • Patent Title: Therapeutic compounds and uses thereof Sep. 03, 2019
  • Patent Title: Crystalline forms of therapeutic compounds and uses thereof Aug. 27, 2019
  • Patent Title: Meropenem derivatives and uses thereof Aug. 27, 2019
  • Patent Title: Compounds and uses thereof Jul. 16, 2019
  • Patent Title: Crystalline forms of therapeutic compounds and uses thereof Jul. 02, 2019
  • Patent Title: Urea derivatives and uses thereof Jun. 25, 2019
  • Patent Title: Urea derivatives and uses thereof Jun. 11, 2019
  • Patent Title: Therapeutic compounds and uses thereof May. 14, 2019
  • Patent Title: Crystalline forms of a therapeutic compound and uses thereof Apr. 09, 2019
  • Patent Title: Crystalline forms of therapeutic compounds and uses thereof Apr. 09, 2019
  • Patent Title: 1-amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof Jan. 08, 2019
  • Patent Title: Crystalline forms of therapeutic compounds and uses thereof Dec. 25, 2018
  • Patent Title: Urea derivatives and uses thereof Aug. 28, 2018
  • Patent Title: Crystalline forms of therapeutic compounds and uses thereof Feb. 13, 2018
  • Patent Title: Therapeutic compounds and uses thereof Jan. 30, 2018
  • Patent Title: Therapeutic compounds and uses thereof Jan. 09, 2018
  • Patent Title: Therapeutic compounds and uses thereof Dec. 05, 2017
  • Patent Title: Therapeutic compounds and uses thereof Nov. 28, 2017
  • Patent Title: Urea derivatives and uses thereof Oct. 31, 2017
  • Patent Title: Crystalline forms of therapeutic compounds and uses thereof Oct. 17, 2017
  • Patent Title: Meropenem derivatives and uses thereof Aug. 08, 2017
  • Patent Title: Therapeutic compounds and uses thereof Jul. 04, 2017
  • Patent Title: Crystalline forms of 4-((4-((4-fluoro-2-methyl-1h-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof Jun. 27, 2017
  • Patent Title: Urea derivatives and uses thereof Feb. 28, 2017
  • Patent Title: Nanocrystals, compositions, and methods that aid particle transport in mucus Jan. 03, 2017
  • Patent Title: Crystalline forms of therapeutic compounds and uses thereof Oct. 04, 2016
  • Patent Title: Nanocrystals, compositions, and methods that aid particle transport in mucus Jul. 19, 2016
  • Patent Title: Nanocrystals, compositions, and methods that aid particle transport in mucus Jul. 19, 2016
  • Patent Title: Therapeutic compounds and uses thereof May. 31, 2016
  • Patent Title: Therapeutic compounds and uses thereof May. 31, 2016
  • Patent Title: Urea derivatives and uses thereof Dec. 15, 2015
  • Patent Title: Nanocrystals, compositions, and methods that aid particle transport in mucus Jun. 16, 2015
  • Patent Title: Functionalized poly(ether-anhydride) block copolymers Jan. 15, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to KALA from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
KALA News

Recent insights relating to KALA

CNBC Recommendations

Recent picks made for KALA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in KALA

KALA Analyst Ratings

KALA Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
KALA Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $KALA stock a Buy, Sell, or Hold?

  • What is the price target for $KALA stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

KALA Top Shareholders
Shareholder
Shares Held
KALA Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $KALA stock?

  • Who owns the most shares of $KALA stock?

  • What funds own $KALA stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

KALA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view KALA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About KALA

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

  • Address Arlington, MA
  • Market Cap 10.8 million
  • Employees 6
  • Industrial Classification Pharmaceutical Preparations

KALA BIO, Inc. Common Stock (KALA) Historical Stock Prices

KALA BIO, Inc. Common Stock (KALA) closed at $0.5600 on September 24, 2026. Over the past year its adjusted close ranged from $0.5073 to $956.75. Daily prices go back to July 20, 2017, 2,307 trading days in all.

  • 1 month-31.79%
  • 3 months-78.04%
  • Year to date-97.99%
  • 1 year-99.94%
  • 3 years-99.89%
  • 5 years-99.99%
  • Max-100.00%
See every congressional and insider trade on the KALA price chart

Quiver Premium charts KALA's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 0.5310 0.5700 0.5250 0.5600 0.5600 694,310
Sep 23, 2026 0.5816 0.5903 0.5600 0.5600 0.5600 83,179
Sep 22, 2026 0.5700 0.6118 0.5502 0.5990 0.5990 136,914
Sep 21, 2026 0.5660 0.5798 0.5432 0.5600 0.5600 51,414
Sep 18, 2026 0.5498 0.5800 0.5310 0.5390 0.5390 81,739
Sep 17, 2026 0.5590 0.5770 0.5345 0.5646 0.5646 124,192
Sep 16, 2026 0.5350 0.5402 0.5110 0.5216 0.5216 174,419
Sep 15, 2026 0.5465 0.5532 0.5002 0.5077 0.5077 180,533
Sep 14, 2026 0.5800 0.5834 0.5353 0.5407 0.5407 182,536
Sep 11, 2026 0.5920 0.5996 0.5723 0.5724 0.5724 111,595
Sep 10, 2026 0.5600 0.6020 0.5503 0.5629 0.5629 309,357
Sep 9, 2026 0.5336 0.6099 0.5290 0.5567 0.5567 534,874
Sep 8, 2026 0.5200 0.5464 0.4901 0.5379 0.5379 175,732
Sep 4, 2026 0.5450 0.5569 0.5006 0.5073 0.5073 261,359
Sep 3, 2026 0.5271 0.5750 0.5201 0.5610 0.5610 577,437
Sep 2, 2026 0.5349 0.5652 0.5030 0.5225 0.5225 441,115
Sep 1, 2026 0.5206 0.5700 0.5100 0.5322 0.5322 9,074,333
Aug 31, 2026 0.6785 0.7600 0.6630 0.6727 0.6727 239,970
Aug 28, 2026 0.8329 1.09 0.5867 0.6901 0.6901 2,416,799
Aug 27, 2026 0.8011 0.8500 0.8011 0.8121 0.8121 32,295
Aug 26, 2026 0.8100 0.8262 0.8100 0.8161 0.8161 61,104
Aug 25, 2026 0.8399 0.8399 0.7901 0.8210 0.8210 21,830
Aug 24, 2026 0.8200 0.8400 0.7817 0.7954 0.7954 56,639
Aug 21, 2026 0.9840 0.9840 0.8000 0.8201 0.8201 100,822
Aug 20, 2026 0.9390 0.9585 0.8101 0.8401 0.8401 64,926
Aug 19, 2026 0.9349 0.9399 0.8900 0.9000 0.9000 35,590
Aug 18, 2026 0.9001 0.9394 0.8703 0.8987 0.8987 36,573
Aug 17, 2026 0.9499 0.9955 0.9000 0.9102 0.9102 117,990
Aug 14, 2026 0.9400 0.9499 0.8768 0.9455 0.9455 32,179
Aug 13, 2026 0.9710 0.9710 0.8601 0.9240 0.9240 104,220
Aug 12, 2026 0.8970 0.9500 0.8190 0.8840 0.8840 62,840
Aug 11, 2026 0.7550 0.8450 0.7500 0.8449 0.8449 81,120
Aug 10, 2026 0.7780 0.8186 0.7254 0.7550 0.7550 124,514
Aug 7, 2026 0.7504 0.7770 0.7200 0.7478 0.7478 43,147
Aug 6, 2026 0.7300 0.7511 0.7065 0.7368 0.7368 47,718
Aug 5, 2026 0.7500 0.7660 0.6951 0.7010 0.7010 40,464
Aug 4, 2026 0.8300 0.8590 0.7418 0.7430 0.7430 127,610
Aug 3, 2026 0.7800 0.8800 0.7200 0.7830 0.7830 57,212
Jul 31, 2026 0.7320 0.7875 0.6700 0.7559 0.7559 71,725
Jul 30, 2026 0.6900 0.7300 0.6500 0.7297 0.7297 95,281
Jul 29, 2026 0.6800 0.7000 0.6301 0.6734 0.6734 37,727
Jul 28, 2026 0.6800 0.6884 0.6150 0.6602 0.6602 46,087
Jul 27, 2026 0.6216 0.7320 0.6152 0.6706 0.6706 76,549
Jul 24, 2026 0.6600 0.7000 0.5900 0.6342 0.6342 127,932
Jul 23, 2026 0.7330 0.7330 0.6026 0.6103 0.6103 246,824
Jul 22, 2026 0.7578 0.7622 0.7012 0.7365 0.7365 116,648
Jul 21, 2026 0.7557 0.8000 0.7320 0.7334 0.7334 104,918
Jul 20, 2026 0.7724 0.8000 0.7320 0.7499 0.7499 78,859
Jul 17, 2026 0.9080 0.9080 0.7640 0.7758 0.7758 188,266
Jul 16, 2026 1.01 1.03 0.8300 0.8471 0.8471 247,755
Jul 15, 2026 0.9800 1.14 0.9800 1.03 1.03 325,490
Jul 14, 2026 1.11 1.11 0.9328 0.9633 0.9633 236,075
Jul 13, 2026 1.15 1.22 1.07 1.09 1.09 211,991
Jul 10, 2026 1.37 1.37 1.16 1.18 1.18 318,833
Jul 9, 2026 1.41 1.41 1.30 1.35 1.35 97,528
Jul 8, 2026 1.51 1.51 1.30 1.39 1.39 156,810
Jul 7, 2026 1.51 1.54 1.44 1.51 1.51 71,259
Jul 6, 2026 1.68 2.04 1.48 1.54 1.54 497,142
Jul 2, 2026 1.80 1.82 1.67 1.68 1.68 75,490
Jul 1, 2026 1.74 1.85 1.62 1.78 1.78 224,016
Jun 30, 2026 2.08 2.08 1.63 1.73 1.73 315,230
Jun 29, 2026 2.54 2.54 2.02 2.09 2.09 194,792
Jun 26, 2026 2.58 2.71 2.46 2.52 2.52 31,977
Jun 25, 2026 2.96 3.01 2.55 2.55 2.55 52,093
Jun 24, 2026 3.09 3.42 2.95 3.00 3.00 71,082
Jun 23, 2026 3.36 3.54 3.11 3.12 3.12 67,649
Jun 22, 2026 3.69 3.71 3.22 3.54 3.54 142,052
Jun 18, 2026 2.85 3.66 2.85 3.61 3.61 959,164
Jun 17, 2026 3.19 3.41 2.81 2.85 2.85 143,213
Jun 16, 2026 2.68 3.19 2.65 3.14 3.14 175,191
Jun 15, 2026 2.68 2.79 2.51 2.64 2.64 90,310
Jun 12, 2026 2.49 2.90 2.47 2.63 2.63 198,283
Jun 11, 2026 2.34 2.54 2.21 2.47 2.47 72,898
Jun 10, 2026 2.35 2.48 2.23 2.39 2.39 74,277
Jun 9, 2026 2.35 2.42 2.21 2.35 2.35 84,424
Jun 8, 2026 2.19 2.56 2.11 2.29 2.29 232,933
Jun 5, 2026 2.25 2.30 2.03 2.06 2.06 127,595
Jun 4, 2026 2.26 2.48 2.21 2.23 2.23 100,105
Jun 3, 2026 2.44 2.47 2.23 2.24 2.24 57,814
Jun 2, 2026 2.22 2.50 2.14 2.39 2.39 127,125
Jun 1, 2026 2.26 2.45 2.19 2.20 2.20 102,647
May 29, 2026 2.42 2.42 2.20 2.23 2.23 61,814
May 28, 2026 2.36 2.41 2.27 2.29 2.29 60,296
May 27, 2026 2.15 2.38 2.13 2.33 2.33 46,091
May 26, 2026 2.43 2.43 2.10 2.17 2.17 134,195
May 22, 2026 2.61 2.66 2.40 2.43 2.43 60,831
May 21, 2026 2.67 2.67 2.48 2.60 2.60 71,623
May 20, 2026 2.61 2.88 2.53 2.65 2.65 88,912
May 19, 2026 2.78 2.80 2.52 2.53 2.53 50,914
May 18, 2026 2.90 2.92 2.60 2.71 2.71 52,383
May 15, 2026 3.02 3.20 2.90 2.93 2.93 51,506
May 14, 2026 3.05 3.12 2.87 3.09 3.09 30,794
May 13, 2026 2.90 3.45 2.90 3.06 3.06 79,980
May 12, 2026 3.82 3.89 2.85 3.12 3.12 168,854
May 11, 20261-for-50 reverse split 3.62 3.96 3.24 3.91 3.91 189,057
May 8, 2026 0.0826 0.0836 0.0660 0.0793 3.96 7,526,253
May 7, 2026 0.0878 0.0888 0.0775 0.0831 4.16 8,210,001
May 6, 2026 0.1136 0.1170 0.0996 0.1151 5.75 1,273,938
May 5, 2026 0.1082 0.1175 0.1082 0.1121 5.61 2,107,875
May 4, 2026 0.1120 0.1160 0.1068 0.1080 5.40 1,627,409
May 1, 2026 0.1100 0.1179 0.1066 0.1090 5.45 3,418,347
Apr 30, 2026 0.1094 0.1102 0.1039 0.1051 5.25 3,104,305
Apr 29, 2026 0.1136 0.1145 0.1030 0.1094 5.47 3,844,743
Apr 28, 2026 0.1194 0.1200 0.1022 0.1145 5.72 4,651,644
Apr 27, 2026 0.1400 0.1650 0.1180 0.1194 5.97 5,458,655
Apr 24, 2026 0.1548 0.1593 0.1350 0.1361 6.80 7,360,344
Apr 23, 2026 0.1767 0.1799 0.1520 0.1540 7.70 3,612,009
Apr 22, 2026 0.1854 0.1929 0.1710 0.1765 8.82 3,979,098
Apr 21, 2026 0.2000 0.2075 0.1800 0.1851 9.26 6,794,236
Apr 20, 2026 0.1900 0.2019 0.1900 0.2000 10.00 1,947,538
Apr 17, 2026 0.1913 0.2052 0.1875 0.1989 9.95 1,690,862
Apr 16, 2026 0.1965 0.1988 0.1800 0.1911 9.55 3,191,772
Apr 15, 2026 0.2236 0.2236 0.1900 0.1988 9.94 3,556,137
Apr 14, 2026 0.2265 0.2265 0.2100 0.2258 11.29 2,058,422
Apr 13, 2026 0.2370 0.2370 0.2010 0.2229 11.14 4,702,769
Apr 10, 2026 0.1900 0.2098 0.1900 0.2030 10.15 3,327,569
Apr 9, 2026 0.1800 0.1876 0.1726 0.1830 9.15 1,619,034
Apr 8, 2026 0.1693 0.1800 0.1648 0.1778 8.89 1,811,876
Apr 7, 2026 0.1698 0.1698 0.1550 0.1613 8.06 1,799,635
Apr 6, 2026 0.1750 0.1798 0.1646 0.1729 8.64 1,564,266
Apr 2, 2026 0.1600 0.1736 0.1455 0.1702 8.51 3,295,329
Apr 1, 2026 0.1800 0.1980 0.1615 0.1630 8.15 5,787,730
Mar 31, 2026 0.1699 0.1799 0.1658 0.1731 8.65 2,038,876
Mar 30, 2026 0.1800 0.1835 0.1610 0.1710 8.55 3,077,447
Mar 27, 2026 0.2041 0.2041 0.1607 0.1757 8.79 4,470,805
Mar 26, 2026 0.2100 0.2223 0.2000 0.2000 10.00 2,112,976
Mar 25, 2026 0.2174 0.2293 0.2131 0.2143 10.71 3,720,449
Mar 24, 2026 0.2347 0.2390 0.2111 0.2124 10.62 3,769,241
Mar 23, 2026 0.2282 0.2442 0.2200 0.2327 11.63 2,914,850
Mar 20, 2026 0.2497 0.2497 0.2210 0.2368 11.84 2,698,712
Mar 19, 2026 0.2525 0.2525 0.2310 0.2459 12.29 3,948,704
Mar 18, 2026 0.2463 0.2528 0.2330 0.2525 12.62 3,227,931
Mar 17, 2026 0.2707 0.2707 0.2373 0.2521 12.61 6,825,715
Mar 16, 2026 0.2800 0.2831 0.2598 0.2664 13.32 5,470,309
Mar 13, 2026 0.2800 0.2899 0.2611 0.2800 14.00 11,502,138
Mar 12, 2026 0.3345 0.3379 0.2877 0.2968 14.84 22,295,676
Mar 11, 2026 0.4568 0.5100 0.3350 0.3649 18.25 291,101,775
Mar 10, 2026 0.2666 0.3180 0.2500 0.2939 14.70 1,226,543
Mar 9, 2026 0.2780 0.2956 0.2325 0.2605 13.03 1,279,940
Mar 6, 2026 0.2800 0.2925 0.2551 0.2781 13.90 1,780,216
Mar 5, 2026 0.3542 0.3544 0.2700 0.2750 13.75 3,022,207
Mar 4, 2026 0.3593 0.3950 0.3370 0.3453 17.27 1,684,880
Mar 3, 2026 0.3910 0.4030 0.3490 0.3507 17.54 586,027
Mar 2, 2026 0.3800 0.4000 0.3724 0.3880 19.40 194,462
Feb 27, 2026 0.3939 0.3969 0.3724 0.3800 19.00 205,829
Feb 26, 2026 0.4064 0.4100 0.3602 0.3800 19.00 403,333
Feb 25, 2026 0.4100 0.4181 0.3836 0.4040 20.20 486,380
Feb 24, 2026 0.3900 0.4192 0.3760 0.4102 20.51 341,226
Feb 23, 2026 0.4100 0.4191 0.3750 0.3806 19.03 368,403
Feb 20, 2026 0.4100 0.4219 0.3753 0.3800 19.00 336,498
Feb 19, 2026 0.4090 0.4187 0.3914 0.4042 20.21 174,073
Feb 18, 2026 0.3940 0.4267 0.3604 0.3800 19.00 732,906
Feb 17, 2026 0.4200 0.4414 0.3801 0.3980 19.90 634,980
Feb 13, 2026 0.3650 0.4196 0.3528 0.4065 20.32 796,285
Feb 12, 2026 0.3988 0.3998 0.3633 0.3633 18.16 873,873
Feb 11, 2026 0.4180 0.4223 0.3811 0.3998 19.99 657,641
Feb 10, 2026 0.4025 0.4329 0.4003 0.4276 21.38 419,337
Feb 9, 2026 0.4408 0.4634 0.4000 0.4150 20.75 747,917
Feb 6, 2026 0.4144 0.4576 0.4010 0.4400 22.00 2,107,673
Feb 5, 2026 0.4292 0.4481 0.3801 0.3990 19.95 648,838
Feb 4, 2026 0.4747 0.4747 0.4131 0.4407 22.04 1,000,048
Feb 3, 2026 0.5274 0.5500 0.4700 0.4703 23.52 1,267,215
Feb 2, 2026 0.5047 0.5429 0.5047 0.5275 26.38 280,573
Jan 30, 2026 0.5270 0.5385 0.5100 0.5300 26.50 522,360
Jan 29, 2026 0.5732 0.5799 0.5300 0.5400 27.00 945,255
Jan 28, 2026 0.5850 0.5900 0.5650 0.5795 28.98 425,598
Jan 27, 2026 0.5642 0.5940 0.5630 0.5940 29.70 621,735
Jan 26, 2026 0.6000 0.6039 0.5700 0.5819 29.09 796,615
Jan 23, 2026 0.5963 0.6050 0.5770 0.6050 30.25 675,231
Jan 22, 2026 0.6000 0.6200 0.5900 0.5900 29.50 828,465
Jan 21, 2026 0.6215 0.6293 0.5810 0.6026 30.13 695,229
Jan 20, 2026 0.6500 0.6500 0.6000 0.6026 30.13 1,018,115
Jan 16, 2026 0.6500 0.7100 0.6156 0.6750 33.75 4,495,562
Jan 15, 2026 0.6351 0.6450 0.6007 0.6007 30.04 551,187
Jan 14, 2026 0.6080 0.6600 0.6050 0.6327 31.64 1,448,949
Jan 13, 2026 0.6168 0.6282 0.6051 0.6091 30.45 635,754
Jan 12, 2026 0.6200 0.6400 0.6114 0.6400 32.00 501,786
Jan 9, 2026 0.6267 0.6496 0.6000 0.6315 31.57 1,449,057
Jan 8, 2026 0.6500 0.6800 0.6213 0.6490 32.45 1,475,435
Jan 7, 2026 0.6370 0.6898 0.6050 0.6650 33.25 3,695,181
Jan 6, 2026 0.6700 0.7373 0.6330 0.6585 32.92 8,660,856
Jan 5, 2026 0.6305 0.6486 0.6094 0.6160 30.80 12,199,037
Jan 2, 2026 0.5614 0.6429 0.5595 0.6211 31.05 815,017
Dec 31, 2025 0.5310 0.5600 0.5303 0.5559 27.80 669,108
Dec 30, 2025 0.6090 0.6090 0.5575 0.5662 28.31 1,244,864
Dec 29, 2025 0.6384 0.6500 0.5811 0.5812 29.06 945,200
Dec 26, 2025 0.6302 0.6600 0.6150 0.6500 32.50 928,703
Dec 24, 2025 0.6000 0.7237 0.5980 0.6402 32.01 3,503,329
Dec 23, 2025 0.5866 0.6260 0.5700 0.5700 28.50 680,954
Dec 22, 2025 0.6180 0.6440 0.5800 0.5866 29.33 990,968
Dec 19, 2025 0.5700 0.6582 0.5700 0.6223 31.11 2,029,433
Dec 18, 2025 0.6100 0.6199 0.5100 0.5786 28.93 1,709,871
Dec 17, 2025 0.5555 0.6700 0.5506 0.5883 29.41 4,606,025
Dec 16, 2025 0.6000 0.6134 0.5500 0.5556 27.78 1,951,561
Dec 15, 2025 0.6592 0.6670 0.6000 0.6062 30.31 2,084,976
Dec 12, 2025 0.7055 0.7298 0.6750 0.6752 33.76 1,392,309
Dec 11, 2025 0.7510 0.8000 0.6679 0.6948 34.74 2,870,261
Dec 10, 2025 0.7855 0.8049 0.7100 0.7699 38.49 2,516,197
Dec 9, 2025 0.7580 0.8642 0.7580 0.7861 39.30 2,305,127
Dec 8, 2025 0.8500 0.8600 0.7507 0.8383 41.91 5,357,433
Dec 5, 2025 1.00 1.02 0.8576 0.9000 45.00 11,339,113
Dec 4, 2025 1.31 1.72 0.9515 0.9640 48.20 180,162,698
Dec 3, 2025 1.08 1.12 0.9000 0.9250 46.25 7,451,465
Dec 2, 2025 1.23 1.37 1.10 1.10 55.00 6,264,314
Dec 1, 2025 1.30 1.91 1.17 1.33 66.50 169,816,902
Nov 28, 2025 0.9558 1.01 0.8477 0.9661 48.30 4,056,837
Nov 26, 2025 0.7970 1.14 0.7013 0.9104 45.52 31,687,095
Nov 25, 2025 0.6200 0.6500 0.6101 0.6383 31.91 3,043,803
Nov 24, 2025 0.6300 0.6533 0.6090 0.6170 30.85 99,282
Nov 21, 2025 0.6504 0.6689 0.6076 0.6200 31.00 107,463
Nov 20, 2025 0.6500 0.6796 0.6169 0.6488 32.44 122,593
Nov 19, 2025 0.6900 0.6999 0.6306 0.6330 31.65 166,409
Nov 18, 2025 0.6863 0.6997 0.6504 0.6888 34.44 161,365
Nov 17, 2025 0.7200 0.7343 0.6754 0.6990 34.95 186,219
Nov 14, 2025 0.6580 0.7200 0.6404 0.7061 35.30 280,112
Nov 13, 2025 0.7300 0.7300 0.6400 0.6580 32.90 218,294
Nov 12, 2025 0.7348 0.7451 0.7048 0.7265 36.33 75,695
Nov 11, 2025 0.7273 0.7698 0.7102 0.7455 37.27 35,445
Nov 10, 2025 0.7315 0.7899 0.7000 0.7310 36.55 402,526
Nov 7, 2025 0.7480 0.7567 0.6965 0.7139 35.70 175,244
Nov 6, 2025 0.7500 0.8000 0.7211 0.7334 36.67 174,102
Nov 5, 2025 0.7378 0.7997 0.7330 0.7623 38.12 79,800
Nov 4, 2025 0.7402 0.7998 0.7402 0.7515 37.58 134,534
Nov 3, 2025 0.8000 0.8100 0.7600 0.7617 38.09 154,057
Oct 31, 2025 0.7500 0.8010 0.7400 0.7800 39.00 148,617
Oct 30, 2025 0.7790 0.7900 0.7540 0.7557 37.78 168,171
Oct 29, 2025 0.8180 0.8180 0.7730 0.7987 39.94 249,364
Oct 28, 2025 0.8107 0.8330 0.7901 0.8330 41.65 248,196
Oct 27, 2025 0.7931 0.8299 0.7791 0.8058 40.29 354,484
Oct 24, 2025 0.7730 0.8300 0.7730 0.7959 39.80 394,376
Oct 23, 2025 0.8200 0.9047 0.7821 0.7822 39.11 666,826
Oct 22, 2025 0.9120 0.9300 0.8230 0.8231 41.16 657,621
Oct 21, 2025 0.8530 0.9820 0.8530 0.9301 46.51 871,423
Oct 20, 2025 0.8778 1.04 0.8000 0.9501 47.51 4,533,883
Oct 17, 2025 1.36 1.36 1.29 1.31 65.50 422,220
Oct 16, 2025 1.37 1.42 1.36 1.38 69.00 361,069
Oct 15, 2025 1.51 1.51 1.35 1.41 70.50 692,397
Oct 14, 2025 1.49 1.52 1.40 1.51 75.50 418,571
Oct 13, 2025 1.43 1.49 1.42 1.49 74.50 248,249
Oct 10, 2025 1.55 1.55 1.40 1.43 71.50 833,486
Oct 9, 2025 1.60 1.60 1.51 1.55 77.50 425,081
Oct 8, 2025 1.63 1.70 1.56 1.57 78.50 753,448
Oct 7, 2025 1.50 1.68 1.50 1.64 82.00 1,151,557
Oct 6, 2025 1.55 1.61 1.51 1.52 76.00 934,148
Oct 3, 2025 1.51 1.69 1.49 1.54 77.00 1,641,294
Oct 2, 2025 1.39 1.54 1.37 1.54 77.00 1,650,525
Oct 1, 2025 1.46 1.48 1.26 1.36 68.00 3,095,624
Sep 30, 2025 1.78 1.95 1.50 1.53 76.50 4,910,318
Sep 29, 2025 1.47 2.46 1.10 2.04 102.25 36,289,004
Sep 26, 2025 18.90 19.48 18.34 19.05 952.50 395,572
Sep 25, 2025 19.02 19.77 18.12 18.22 911.00 167,909
Sep 24, 2025 17.07 19.37 16.51 19.14 956.75 276,111

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
KALA BIO, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at KALA, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation